Founded in 2002, 5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to investors. The firm supports companies solving important healthcare needs via cutting-edge breakthroughs in medicine and science. 5AM Ventures' portfolio companies spearhead novel approaches to diagnose, prevent and treat a wide range of medical conditions. 5AM Ventures has approximately $1 billion under management and offices in San Francisco (Menlo Park) and Boston.
Investors & Funding
Founded in 1989, OrbiMed scouts the globe for innovations that will help ensure humanity lives healthier, longer and more productive lives. The firm has been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Their team of over 80 distinguished scientific, medical, investment and other professionals manages over $14 billion across public and private company investments worldwide. Orbimed has offices in New York, San Francisco, Mumbai, Herzliya, and Shanghai.
Founded in 1999, Perceptive Advisors focuses on supporting progress in the life sciences industry by identifying opportunities and directing financial resources toward the most promising technologies in modern healthcare. Today, the firm manages approximately $3 billion+ across several strategies. The Perceptive Advisor offices are located in New York City.
Founded in 2001, RA Capital is a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics. The flexibility of its strategy allows the firm to provide seed funding to startups and to lead private, IPO, and follow-on financings for its portfolio companies, both facilitating the crossover process and allowing management teams to drive value creation with fewer capital concerns from inception through commercialization. The RA Capital offices are in Boston.
Founded in 1999, Versant Ventures is a leading global healthcare investment firm committed to helping exceptional entrepreneurs build the next generation of great healthcare companies. The firm invests across the healthcare sector and at all stages of company development, with an emphasis on the discovery and development of novel therapeutics. Versant has built a team with deep investment, operating, and scientific expertise that enables a hands-on approach to company building. Versant has $1.9 billion under management and offices in North America and Europe.
Founded in 1996, Vivo Capital is a global healthcare investment firm focused on investing in and building high quality companies. Vivo’s current portfolio includes more than 80 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices. With more than $1.8 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising technologies. Vivo Capital has offices in Palo Alto, Beijing, Shanghai, and Taipei.